“Intravitreal Dexamethasone an Effective Treatment in Cases of Recurrent Macular Oedema in Crvo”

Abstract

Retinal vein occlusion is second most common retinal vascular disease after diabetic retinopathy. Macular oedema secondary to RVO is the second most common retinal vascular disease after diabetic retinopathy. Various treatment options have been mentioned in literature i.e., Anti VEGF injections, retinal laser, corticosteroids, vitrectomy, etc. We here with report a case of CRVO with recurrent macular edema even after 2 monthly doses of intravitreal ranibizumab injections who responded very well by single intravitreal injection of dexamethasone implant (Ozurdex). Till 3 months post injection of single dexamethasone implant, visual acuity was stable at 6/12 with maintaining of central foveal thickness below 250 microns without requiring of any other further mode of treatment. So we conclude that dexamethasone intravitreal implant is a very good effective mode of treatment in such cases of CRVO with recurrent macular edema.